Answers are grounded in this paper and cite their sources.
Evaluates anti-inflammatory effects in diabetic rats using metformin and dapagliflozin, indicating potential therapeutic benefits.
Context: Chronic inflammation is a hallmark of diabetes mellitus and contributes significantly to its complications. The interplay between hyperglycemia and inflammation forms a vicious cycle that exacerbates disease progression. Recent evidence suggests that drugs such as metformin and sodium-glucose cotransporter-2 inhibitors like dapagliflozin may exert anti-inflammatory effects in addition to glycemic control. Aims: To evaluate the impact of diabetes on chronic inflammation using complete Freund’s adjuvant (CFA)-induced arthritis model in male Wistar rats and to investigate anti-inflammatory effects of metformin, dapagliflozin, and their combination in diabetic rats. Materials and Methods: Diabetes was induced using streptozotocin (40 mg/kg, i.p.), and chronic inflammation was modelled using CFA injection in the right hind paw. Diabetic rats were treated with metformin (180 mg/kg), dapagliflozin (0.9 mg/kg), or their combination for 28 days. Paw edema was measured at defined intervals, and inflammatory changes of ankle joints were analysed by histopathological analysis. Statistical Analysis Used: Data were expressed as mean ± standard error of the mean and analyzed using one-way analysis of variance followed by Tukey’s post hoc test. P ≤ 0.05 was considered statistically significant. Results: Diabetic rats exhibited significantly increased inflammatory parameters as compared to normal controls, while all treatments significantly reduced inflammation, with combination therapy showing efficacy comparable to monotherapy and aspirin. Conclusions: Diabetes exacerbates chronic inflammation in the CFA-induced arthritis model. Metformin and dapagliflozin, individually and in combination, demonstrated anti-inflammatory properties. Their concurrent use may provide a therapeutic benefit in addressing chronic inflammation associated with diabetes.
No takes yet. Share an insight, caveat, or question.
Hashilkar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: